OCCIDENT
Venture Capital
Active
Munchen, Germany
37
14M
21
1.19
7
0.43
- Stages of investment
- Areas of investment
Summary
OCCIDENT is the famous VC, which was founded in 1993. The fund was located in Europe if to be more exact in Switzerland. The main office of represented VC is situated in the Zug.
The important activity for fund was in 2018. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Among the various public portfolio startups of the fund, we may underline advanceCOR, iThera Medical, Implandata Ophthalmic Products Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Diagnostics, Pharmaceutical.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the OCCIDENT, startups are often financed by Venture Kick, Zu00fcrcher Kantonal Bank, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, High-Tech Gru00fcnderfonds, KfW. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, Eurostars, Alpana Ventures.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
- Check size
- 500K — 1M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 37
- Lead investments
- 7
- Rounds per year
- 1.19
- Follow on index
- 0.43
- Investments by industry
- Health Care (20)
- Biotechnology (14)
- Medical Device (13)
- Therapeutics (8)
- Medical (7) Show 26 more
- Investments by region
-
- Germany (15)
- Switzerland (20)
- Finland (1)
- Slovenia (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 45M
- Group Appearance index
- 0.95
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| hemotune | 25 Mar 2024 | Biotechnology, Health Care, Medical Device, Life Science, Therapeutics | Early Stage Venture | 15M | Switzerland, Zurich, Zurich |
| Tubulis | 03 May 2022 | Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics | Early Stage Venture | 70M | Munich, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.